Sandbox carlos: Difference between revisions

Revision as of 17:56, 16 July 2015

2.2 Secondary prophylaxis (preventing recurrence in patients with CD4 count < 200 cells/mm³)

Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
Alternative regimen (1): Trimethoprim-sulfamethoxazole 160 mg/800 mg PO qd
Alternative regimen (2): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
Alternative regimen (3): Pyrimethamine 25 mg PO qd AND Leucovorin 5–10 mg PO qd
Alternative regimen (4): Ciprofloxacin 500 mg PO 3 times weekly
Note: Criteria for discontinuation of chronic maintenance therapy: sustained increase in CD4 count > 200 cells/mm³ for > 6 months in response to ART and without evidence of active Cystoisospora belli infection

Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO OR IV qid for 10 days

Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days

Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
Alternative regimen (1): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
Alternative regimen (2): Pyrimethamine 25 mg PO daily AND Leucovorin 5–10 mg PO daily
Alternative regimen (3): Ciprofloxacin 500 mg PO 3 times weekly

@@ Line 1: / Line 1: @@
-{{PBI|Cytoisospora belli}}
+{{PBI|Cystoisospora belli}}
+:* 1. '''Cystoisospora belli treatment'''
+:* 2. '''Cystoisospora belli prophylaxis'''
+::* 2.1 '''Primary prophylaxis'''
+::* 2.2 '''Secondary prophylaxis (preventing recurrence in patients with CD4 count < 200 cells/mm<sup>3</sup>)'''
+:::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly
+:::* Alternative regimen (1): [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO qd
+:::* Alternative regimen (2): [[Trimethoprim-sulfamethoxazole]] 320 mg/1600 mg PO 3 times weekly
+:::* Alternative regimen (3): [[Pyrimethamine]] 25 mg PO qd {{and}} [[Leucovorin]] 5–10 mg PO qd
+:::* Alternative regimen (4): [[Ciprofloxacin]] 500 mg PO 3 times weekly
+:::* Note: Criteria for discontinuation of chronic maintenance therapy: sustained increase in CD4 count > 200 cells/mm<sup>3</sup> for > 6 months in response to ART and without evidence of active Cystoisospora belli infection
+----
 :*'''Immunocompetent'''<ref name=CDC Parasites - Cystoisosporiasis>{{cite web | title = CDC - Cystoisosporiasis| url = http://www.cdc.gov/parasites/cystoisospora/health_professionals/index.html }}</ref>
 ::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days